J.W. Cole Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.38M Sell
43,207
-17,169
-28% -$1.39M 0.06% 335
2026
Q1
$5.23M Buy
60,376
+19,695
+48% +$1.89M 0.18% 113
2025
Q4
$1.38M Sell
40,681
-5,859
-13% -$569K 0.03% 530
2025
Q3
$4.43M Buy
46,540
+21,099
+83% +$1.94M 0.08% 231
2025
Q2
$2.22M Buy
25,441
+6,824
+37% +$579K 0.05% 385
2025
Q1
$1.67M Buy
18,617
+8,839
+90% +$791K 0.05% 370
2024
Q4
$781K Buy
9,778
+328
+3% +$28.4K 0.03% 487
2024
Q3
$851K Sell
9,450
-4,514
-32% -$380K 0.04% 433
2024
Q2
$1.1M Sell
13,964
-3,233
-19% -$265K 0.05% 334
2024
Q1
$1.5M Sell
17,197
-381
-2% -$32.5K 0.08% 258
2023
Q4
$1.45M Buy
17,578
+8,695
+98% +$663K 0.08% 240
2023
Q3
$696K Buy
8,883
+458
+5% +$38.3K 0.05% 327
2023
Q2
$742K Buy
8,425
+587
+7% +$50.5K 0.05% 332
2023
Q1
$632K Buy
7,838
+1,305
+20% +$106K 0.05% 390
2022
Q4
$508K Sell
6,533
-519
-7% -$42.1K 0.04% 415
2022
Q3
$569K Sell
7,052
-252
-3% -$22.6K 0.05% 361
2022
Q2
$656K Buy
7,304
+751
+11% +$76.1K 0.05% 342
2022
Q1
$727K Buy
6,553
+327
+5% +$34.5K 0.05% 352
2021
Q4
$644K Hold
6,226
0.04% 387
2021
Q3
$780K Buy
6,226
+115
+2% +$14.9K 0.06% 199
2021
Q2
$758K Buy
6,111
+326
+6% +$40.9K 0.06% 330
2021
Q1
$683K Buy
5,785
+100
+2% +$11.7K 0.07% 315
2020
Q4
$666K Sell
5,685
-13,214
-70% -$1.45M 0.07% 289
2020
Q3
$1.96M Buy
+18,899
New +$1.9M 0.15% 155
2020
Q1
Sell
-6,204
Closed -$704K 347
2019
Q4
$704K Buy
+6,204
New +$681K 0.09% 238

Other funds holding MDT

J.W. Cole Advisors's MDT Position: Q2 2026 in Review

J.W. Cole Advisors reduced its Medtronic (MDT) stake by 28% in Q2 2026, selling an estimated $1.39M and leaving 43,207 shares worth $3.38M. The position accounts for 0.06% of the portfolio, ranked #335.

J.W. Cole Advisors first reported a position in MDT in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.23M in Q1 2026. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • J.W. Cole Advisors held 43,207 shares of Medtronic worth $3.38M as of Q2 2026.
  • J.W. Cole Advisors sold 17,169 Medtronic shares in Q2 2026, an estimated $1.39M.
  • Medtronic made up 0.06% of J.W. Cole Advisors's portfolio in Q2 2026, its #335 holding.
  • J.W. Cole Advisors first reported a position in Medtronic in Q4 2019 and has held it in 25 quarters since.
  • J.W. Cole Advisors's Medtronic position peaked at $5.23M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.